Related Experiment Video
Updated: Oct 24, 2026
Endoscopic Cholesteatoma Surgery
Published on: January 19, 2022
Cholesteatoma in the pediatric age group
D R Edelstein1, S C Parisier, G S Ahuja
1Department of Otolaryngology-Head and Neck Surgery, Manhattan Eye, Ear and Throat Hospital, New York, NY 10021.
Insights
Pediatric cholesteatoma management involves various surgical approaches. This study found that surgical treatment for cholesteatoma in children resulted in low rates of residual disease (8%) and recurrence (3%), with hearing maintained or improved in most cases.
Area of Science:
- Otolaryngology
- Pediatric Surgery
- Medical Diagnostics
Background:
- Cholesteatoma diagnosis and management in children present unique challenges and ongoing debate.
- The senior author has extensive experience, treating 320 cholesteatoma patients over 15 years.
- This report focuses on 125 pediatric patients (18 years and younger) treated by the senior author.
Purpose of the Study:
- To analyze the outcomes of surgical management for cholesteatoma in pediatric patients.
- To evaluate the effectiveness of different surgical techniques based on disease extent and patient factors.
- To assess hearing outcomes, residual disease rates, and recurrence rates in this cohort.
Main Methods:
- Retrospective compilation of data from 125 pediatric patients with cholesteatoma.
- Data sources included medical history, physical exams, audiograms, radiographs, questionnaires, surgical findings, and postoperative observations.
- Surgical approach selection was based on disease extent, mastoid configuration, and eustachian tube function assessment.
Main Results:
- Surgical approaches included middle ear tympanotomy (17%), canal wall up (31%), and canal wall down (52.3%).
- Average follow-up was 3.9 years (range: 3 months to 13.5 years).
- Hearing was maintained or improved in the majority of patients; residual disease occurred in 8% and recurrence in 3%.
Conclusions:
- Surgical interventions for pediatric cholesteatoma demonstrate favorable outcomes regarding disease control.
- The chosen surgical strategies effectively managed cholesteatoma in children, with low recurrence rates.
- Maintaining or improving hearing function is achievable in most pediatric cholesteatoma cases treated surgically.
Abstract:
The diagnosis and management of cholesteatoma in children remains controversial. In the past 15 years, the senior author (S.C.P.) has treated 320 patients with cholesteatoma. Patients 18 years and younger composed 40% (125) of the overall group and are the basis for this report. The patient data were compiled using the history, physical examination, audiograms, radiographs, patient questionnaires, surgical findings, and postoperative observations. The surgical treatment selected was determined by the extent of disease, the configuration of the mastoid, and a clinical assessment of eustachian tube function. A middle ear tympanotomy approach was used in 17% of the patients, a canal wall up procedure in 31%, and a canal wall down procedure in 52.3%. The average clinical follow-up was 3.9 years, with the range being from 3 months to 13.5 years. Hearing was maintained or slightly improved in a majority of cases. Residual disease occurred in 8% of patients, and recurrent disease in only 3%.
